NET Patient Foundation Research Abstracts
NPF and NCRAS Public Health England partnership project has been compiling statistics on the incidence, prevalence and survival of NET patients in England using English cancer registry data, with an aim to also access Scottish, Welsh and Northern Irish cancer registry data to also get UK wide statistics.
We carried out four pieces of research in 2017, abstracts for which can be found below:
- The Incidence and Prevalence of Neuroendocrine Tumours in England.
- The 1- year survival rates for Neuroendocrine tumour patients in England.
- Metachronus primary cancers in Neuroendocrine tumour patients.
- Neuroendocrine Tumour patients experiences of support in the community setting across the treatment trajectory.
Presenting symptoms and delay in diagnosis of gastrointestinal and pancreatic Neuroendocrine tumours
Ileocolonic neuroendocrine tumours identified in the English bowel cancer screening programme
Self-reported side effects in neuroendocrine tumour (NET) patients prescribed somatostatin analogues – the role for specialist dietitians and nurses
- Assess what symptoms/side effects patients report on SSA’s.
- Assess the severity of symptoms/side effects reported by patients whilst on SSA’s.
- Produce recommendations on how to deal with symptoms commonly experienced by patients on SSA’s.
This study has been accepted to be published in the British Journal of Nursing.
Recent News
Private Members Bill on Rare Cancer – please write to your MP
Dr Scott Arthur MP (Lab, Edinburgh SW) has introduced a Private Members Bill on Rare Cancers that sets out to raise awareness and tackle some of the issues facing research and clinical trial availability and access within the rare cancer community. It includes three...
Not Just NE Cancer podcast – New episode release
If you've been following the Not Just NE Cancer podcast series, you'll know that our host, Cathy has spoken to a whole range of different guests, including experts in the world of neuroendocrine cancer and wider healthcare as well as neuroendocrine cancer patients and...
Improving cancer pathways: Challenges, Overcoming Barriers and Digital Solutions
A recently published report from Public Policy Projects (PPP) and Civica recommends accelerating the uptake of digital technology integration to improve cancer pathway outcomes. The report, titled “Improving cancer pathways: Challenges, Overcoming Barriers and...